Status:
UNKNOWN
Assessment of Immune Response After Vaccination Against COVID-19 in Patients Treated With Renal Replacement Therapy
Lead Sponsor:
Medical University of Gdansk
Conditions:
Kidney Failure, Chronic
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Chronically dialyzed patients and kidney transplant recipients have been identified as particularly vulnerable to SARS-CoV-2 infection due to unavoidable exposure. They have also high rates of comorbi...
Detailed Description
1. Venous blood samples will be collected at seven-time points: before dose 1 of vaccine, 21 days after dose 1, within 14-21 days after dose 2 and 3,6,9,12 months after vaccination. From the volume of...
Eligibility Criteria
Inclusion
- patients on chronic dialysis (hemodialysis or peritoneal dialysis) for at least 1 months and had received vaccination with mRNA vaccine BNT162b2 (BionTech/Pfizer Comirnaty) with a 3-week interval between first and second doses.
Exclusion
- (-)
Key Trial Info
Start Date :
February 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04905862
Start Date
February 15 2021
End Date
December 31 2022
Last Update
February 4 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Gdansk
Gdansk, Pomeranian Voivodeship, Poland, 80-211
2
7th Naval Hospital in Gdansk
Gdansk, Poland
3
NZOZ Diaverum Gdynia
Gdynia, Poland
4
The University Centre of Maritime and Tropical Medicine in Gdynia
Gdynia, Poland